ACTH (1-39) Market Share Driven by Peptide Therapeutics Research and Pharmaceutical Development | Valuates Reports

ACTH (1-39) Market
The global market for ACTH (1-39) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-16Q10304/Global_ACTH_1_39_Market_Insights_Forecast_to_2028

The ACTH (1-39) market is expanding steadily as peptide-based research and hormone-related pharmaceutical development continue to gain prominence in biomedical science. Adrenocorticotropic hormone peptides are widely utilized in laboratory research, drug development studies, and endocrine investigations, contributing to overall market size and sustained market growth. Growing interest in synthetic peptides for targeted therapeutic applications, alongside advancements in peptide synthesis and purification technologies, is shaping current market trends. Increasing demand from biotechnology firms and pharmaceutical laboratories focused on hormone regulation and inflammatory pathway research further supports positive market dynamics.

By type, Human ACTH (1-39) holds the largest market share due to its relevance in pharmaceutical research and clinical-related applications. Its structural alignment with endogenous human hormone sequences makes it particularly valuable for therapeutic modeling and endocrine studies. Rat ACTH (1-39) is also experiencing consistent market growth, primarily driven by preclinical and laboratory-based animal model research. Other variant forms contribute to niche research needs, supporting diversified product offerings and reinforcing overall market expansion across research institutions and pharmaceutical developers.

In terms of application, the Pharmaceutical segment accounts for the dominant market share, reflecting strong utilization of ACTH (1-39) peptides in drug discovery programs, hormonal therapy research, and inflammatory disease studies. Pharmaceutical laboratories rely on high-purity peptide formulations to ensure experimental accuracy and regulatory compliance. The Other application category, including academic and institutional research, is demonstrating stable market growth as universities and research centers continue exploring endocrine signaling mechanisms and peptide-based innovations. These application dynamics collectively strengthen long-term market growth prospects.

Key companies active in the competitive landscape include AnaSpec, Abbiotec, PolyPeptide Group, Bertin Bioreagent, and Beyotime Biotechnology. These organizations maintain significant market share through specialized peptide synthesis capabilities, stringent quality control standards, and strong distribution networks serving pharmaceutical and research clients. Competitive strategies focus on high-purity product development, customized peptide synthesis services, and expansion into emerging biotechnology markets.

Regionally, North America holds a leading market share, supported by a strong biotechnology ecosystem, advanced pharmaceutical research infrastructure, and consistent investment in endocrine and inflammatory disease studies. Europe maintains a solid market size due to established research institutions and expanding life sciences innovation across Germany, France, the UK, and Italy. Asia-Pacific is witnessing notable market growth, particularly in China, Japan, South Korea, and Taiwan, driven by increasing research funding and expanding biopharmaceutical capabilities. Southeast Asia and Latin America are gradually strengthening their presence through rising academic research and pharmaceutical manufacturing activity. The market forecast indicates sustained expansion as peptide therapeutics research advances, pharmaceutical pipelines diversify, and global research capacity continues to grow.

Segment by Type

• Human
• Rat
• Other

Segment by Application

• Pharmaceutical
• Other

By Company

AnaSpec, Abbiotec, PolyPeptide Group, Bertin Bioreagent, Beyotime Biotechnology

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-16Q10304/global-acth-1-39

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.